ENTITY
Sansure Biotech

Sansure Biotech (688289 CH)

47
Analysis
Health Care • China
Sansure Biotech Inc. operates as an in vitro diagnostic solution provider. The Company develops and sells upstream nucleic acid extraction kits, novel coronavirus nucleic acid detection kits, and other products. Sansure Biotech markets its products worldwide.
more
bearish•WuXi AppTec
•28 Aug 2026 13:50

Quiddity Leaderboard CSI Medical Dec26: US$408mn One-Way Flows; 5 ADDs/DELs Expected

Most of the expected ADDs/DELs could have more than 1x ADV to trade during the December 2026 index rebal event. Although the reference period is...

Share
bearish•Quantitative Analysis
•23 Aug 2026 10:15

A-Share Margin Trading Weekly (Aug 21st): COSCO SHIPPING, EAST MONEY INFORMATION, Mindray, CNOOC

We analyzed A-share margin trading positions report for the past week and highlighted COSCO SHIPPING, EAST MONEY INFORMATION, Mindray, CHENGDU...

Logo
116 Views
Share
•30 Jul 2026 14:12

Quiddity Leaderboard CSI Medical Dec26: Expected ADDs Are Underperforming Expected DELs

The current expected ADDs have underperformed the current expected DELs in the last month. This is another example of the negative momentum in some...

Share
•07 Jul 2022 08:51

Monkeypox and Its Impact on China

Monkeypox's rapid spread raises concerns. China bears the pressure of imported cases, but it’s difficult to replicate the growth story of COVID-19...

Logo
553 Views
Share
•18 Jun 2026 16:30

Quiddity Leaderboard CSI Medical Dec26: 6 ADDs/DELs Expected; US$236mn One-Way Flows

Most expected ADDs/DELs have between 1x-4x ADV to trade and flow sizes of US$25mn-US$45mn. Beijing Wantai Bio (603392 CH) is the most significant...

Share
x